World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 8 August 2016
Main ID:  NCT02665715
Date of registration: 25/01/2016
Prospective Registration: No
Primary sponsor: Amirsalar Samkani
Public title: Can Postprandial Reactive Hypoglycaemia be Reduced in Patients After Roux-en-Y Gastric Bypass With a Low Carbohydrate Diet?
Scientific title: Can Postprandial Reactive Hypoglycaemia be Reduced in Patients After Roux-en-Y Gastric Bypass With a Low Carbohydrate Diet?
Date of first enrolment: August 2015
Target sample size: 10
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02665715
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science  
Phase:  N/A
Countries of recruitment
Denmark
Contacts
Name:     Sten Madsbad, MD, Prof
Address: 
Telephone:
Email:
Affiliation:  Hvidovre University Hospital
Name:     Kirstine Bojsen-Moller, MD, Postdoc
Address: 
Telephone:
Email:
Affiliation:  Hvidovre University Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- RYGB operated patients more than 12 month after operation

- Stable in weight for at least 3 months (+/- 3 kg)

- Plasma glucose below 3.4 mmol/L after screening with test meal (Fresubin drink) or
with continuous glucose monitoring

Exclusion Criteria:

- Fasting plasma glucose concentration > 7mmol/L

- Critical illness

- Hgb < 6.5 mM

- Pregnancy or breastfeeding



Age minimum: 25 Years
Age maximum: 70 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Bariatric Surgery (Gastric Bypass)
Intervention(s)
Other: Low carbohydrate meals
Other: Standard carbohydrate meals
Primary Outcome(s)
Nadir plasma glucose [Time Frame: 0-240 min, 240-480 min]
Secondary Outcome(s)
Time to nadir glucose [Time Frame: 0-240 min, 240-480 min]
Peak plasma glucose [Time Frame: 0-240 min, 240-480 min]
Time to peak glucose [Time Frame: 0-240 min, 240-480 min]
Postprandial incremental GLP-1 area [Time Frame: 0-240 min, 240-480 min]
Time below basline glucose concentrations [Time Frame: 0-480 min]
Postprandial decremental glucose area [Time Frame: 0-240 min, 240-480 min]
Glycemic excursions [Time Frame: 0-480 min]
Postprandial incremental insulin area [Time Frame: 0-240 min, 240-480 min]
Postprandial incremental glucose area [Time Frame: 0-240 min, 240-480 min]
Secondary ID(s)
DK-REAKTIV-15
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Hvidovre University Hospital
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history